Bioethics Forum, the Hastings center, 24 oct 2013
Authors: Joan Rachlin, Avery Avrakotos, and Elisa Hurley
“Some of the most hotly debated questions making the rounds these days include who should interpret, distribute, review, and receive data, and with good reason. From WikiLeaks to National Security Agency whistleblowers, the problems of data privacy, data security, data accuracy, and data availability are making headlines. Over the summer, The New York Times ran a piece about Peter Doshi, a 32-year-old postdoctoral fellow at Johns Hopkins University, who has been pressing pharmaceutical companies to make their clinical trial data public.”
Find article here.